FDA Investigator Anastasia G Lolas

Anastasia G Lolas has conducted inspections on 10 sites in 6 countries as of 14 Mar 2011. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
10
Last Inspection Date:
14 Mar 2011
Investigator Role:
FDA Investigator
Redica ID:
100005684
Countries of Inspections:
Lithuania, United Kingdom of Great Britain and Northern Ireland, United States of America, Switzerland, Austria, Belgium
FDA Investigators that have inspected at least one site in common with Anastasia G Lolas:
Alice S Tsao, Amy Devlin, PhD, Andrea Siegel, PhD, Anita Narula, PhD, Anita R Michael, Anjali Shukla, PhD, Ann Marie Montemurro, Ashutosh Rao, PhD, Bo Chi, PhD, Brandon C Heitmeier, Brenda W Uratani, PhD, Brian M Janelsins, PhD, Brooke K Higgins, Burnell M Henry, Carl A Anderson, Carolyn A Renshaw, Chaltu Nwakijra, Charles I Ann, Charles M Edwards, Christopher T Middendorf, Concepcion Cruz, Jr, Cynthia Jim, CSO, Dennis Cantellops Paite, Diane L Raccasi, Donald C Obenhuber, PhD, Dr. Barbara D Paul, PhD, Dr. Ralph M Bernstein, PhD, Dr. Zhihao Qiu (Peter), PhD, Erika V Butler, Frances Namuswe, PhD, Gerald B Seaborn, Jr, Gwyn G Dickinson, Helen B Ricalde, Herbert M Corbello, Holly Brevig, Ivis L Negron, Jacqueline Mdiaz Albertini, Jee Chung, PhD, Jennifer Swisher, PhD, John P Mistler, Jonathan W Chapman, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose M Cayuela, Juhong Liu, PhD, Julianne C Mccullough, Julie D Bringger, Kalavati Suvarna, PhD, Katherine E Jacobitz, Katherine Szestypalow, Kathy Lee, Kent C Faul, Kevin A Gonzalez, Kevin D Kallander, Kim Lthomas Cruse, Libia M Lugo, Linda Thai, LT Richard A Lyght, Madushini Dharmasena, PhD, Maria Cecilia Tami, PhD, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Marie F Morin, Marvin D Jones, Mary E Farbman, PhD, Mary E Storch, Matthew R Noonan, Maxwell Van Tassell, PhD, Meredith P Soehl, Investigator, Michael E Maselli, Michael Shanks, MS, Minh D Phan, Mra Davism, Mra Mcculloughj, Nadeem I Chaudhry, Nebil A Oumer, Nicholas A Violand, Omotunde O Osunsanmi, Pankaj H Amin, Patricia D Stahnke, Patricia F Hughes, PhD, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Prajakta A Varadkar, Rachael O Oyewole, Rachel C Harrington, Ram Sihag, PhD, Ramesh Potla, PhD, Raquel Gonzalez Rivera, Ravichandran Veerasamy, PhD, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Robert C Coleman, Robert J Martin, Robert Rodriguez, Roger F Zabinski, Rose Ashley, Russell J Glapion, Sang Bong Lee, Santos E Camara, Scott R Nichols, PhD, Seneca D Toms, Shadia Zaman, PhD, Sharon K Thoma, PharmD, Sidney B Priesmeyer, Stephen D Brown, Steven E Bowen, PhD, Steven Fong, MS, PhD, Susan P Bruederle, Teegan Dellibovi Ragheb, PhD, Tekalign Wondimu, Thomas E Friel, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tracy Denison, PhD, Vaishali J Patel, Vlada Matusovsky, Wayne E Seifert, Wendy G Tan, PhD, William Hallett, PhD, Xiaokuang Lai, PhD, Xiaoshi N Wang, Yanming An, PhD, Yasamin Ameri, Ying Xin Fan, PhD, Zhong Li, PhD

Anastasia G Lolas's Documents

Publish Date Document Type Title
January, 2009 FDA 483 FUJIFILM Diosynth Biotechnologies UK Ltd - Form 483, 2009-01-09

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more